Cassava Sciences to pay $31.25M to settle securities class action suit
Cassava Sciences (SAVA) announced on Tuesday that it agreed to pay $31.25M to settle a class action lawsuit pending in a...
News / Analytics / Reviews
Cassava Sciences (SAVA) announced on Tuesday that it agreed to pay $31.25M to settle a class action lawsuit pending in a...
Cassava Sciences (SAVA) fell ~14% in the premarket on Friday after the company said it will be forced to delay a clinical...
Cassava Sciences (SAVA) said in a filing the FDA has asked for more information before allowing its investigational new...
Cassava Sciences has popped 10% in after-market-close trading Monday following an SEC filing indicated that CEO Richard...
Shares of Cassava Sciences (SAVA) added ~5% in the premarket on Friday after Richard Barry, President and Chief Executive...
Cassava Sciences (SAVA) has filed a shelf registration statement with the SEC to offer up to $200 million worth of mixed...
Cassava Sciences (NASDAQ:SAVA) shares rose as much as 6% premarket on Friday after a U.S. court dismissed a criminal case...
Cassava Sciences (NASDAQ:SAVA) president & CEO Richard Barry has disclosed a purchase of 237,941 shares of the...
Cassava Sciences press release (NASDAQ:SAVA): Q2 GAAP EPS of -$0.92. Cash and cash equivalents were $112.4 million, with no...
Cassava Sciences (NASDAQ:SAVA) has appointed Joseph Hulihan as chief medical officer. He will devote approximately half of...